Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services - 21/09/21
Résumé |
The COVID-19 pandemic has presented a unique set of challenges to cancer care centers around the world. Diagnostic and treatment delays associated with lockdown periods may be expected to increase the total number of avoidable skin cancer deaths. During this unprecedented time, dermatologists have been pressed to balance early surgical interventions for skin cancer with the risk of viral transmission. This article summarizes evidenced-based recommendations for the surgical management of cutaneous melanoma, keratinocyte cancer, and Merkel cell carcinoma during the COVID-19 pandemic. Additional long-term studies are required to determine the effect of COVID-19 on skin cancer outcomes.
Le texte complet de cet article est disponible en PDF.Keywords : Surgical delay, Evidence-based guidelines, Time to surgery, Skin cancer, COVID-19, COVID-19 delays, Survival
Plan
Vol 39 - N° 4
P. 627-637 - octobre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.